Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venus: DTaP-IPV Combination Vaccine in Healthy Infants
NCT02458183Phase 3Completed
- Sponsor
- Boryung
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed) in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Boryung. Started Feb 2015; status: completed.
02
Drugs
diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed)
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT02458183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458183.